Hematologist, Transplant Physician. | Opinions expressed are my own and not in any official or professional capacity. UPMC Hillman Cancer Center, Harrisburg
👉👉👉MPN Workshop of the Carolinas 2026 just completed! ✔️ Co-founded by @mpdrc & @doctorpemm in partnership with @spahec 👏 We had a super successful patient-centered research 💡 meeting for developing & discussing new ideas 💡 for the #MPNSM field! 🙏 to our stellar faculty!
Great connecting with @doctorpemm@mpdrc , and @bose_prithviraj at the 2026 MPN Workshop of the Carolinas.
Always valuable to exchange ideas, discuss where the MPN field is headed, and spend time with colleagues and friends who continue to advance the field.
Thanks for the invitation to speak on Telomerase Inhibition in MPNs #Myelofibrosis #Hematology #MPNWorkshop2026 #MPNcarolinas #MPNsm
Excited and proud to share our special issue on #Leukemia that @ljmedeirosMD & I put together for @Human_Pathology We brought together incredible experts to write about the latest in the field.
13 articles, each one #hemepath GOLD💎! 1/14🧵
Starting with our intro to the issue https://t.co/f6ItnXL1id
Posttransplant cyclophosphamide significantly reduced GVHD incidence but not TA-TMA incidence, which predated acute #GVHD in ∼50% of cases. Read the study in Blood Advances: https://t.co/OB4HSA6kdT
Honored to participate as faculty at the 2026 Best of ASCO® Portland and present the latest updates in leukemia.
A wonderful opportunity to reconnect with colleagues, exchange ideas, and discuss advances across hematologic malignancies.
Thank you to Program Co-Chairs Dr. Alexandra Zimmer and Dr. Matthew Solhjem, and to the entire @TotalHealthConf Taylor Love and Keeton Holcomb—for another outstanding program.
As the final weekend of this year’s Best of ASCO® series, special recognition to the Total Health team for traveling across the country, weekend after weekend, to bring meaningful oncology education to our communities.
Grateful to be part of it!
#BestOfASCO #ASCO2026 #Leukemia #Hematology @UPMCHillmanCC@UPMC@UPMCPhysicianEd
Honored to have participated as faculty at the 2026 Best of ASCO® Pittsburgh meeting, presenting the latest updates in leukemia.
Grateful for the opportunity to reconnect with colleagues, exchange ideas, and discuss advances across hematologic malignancies. Thank you to the Total Health team for an outstanding program.
#BestOfASCO #ASCO2026 #Leukemia #UPMCHillmanCenter #Pittsburgh
A milestone for patients with blood cancers: Today, FDA approved the first Treg cell-based immunotherapy to improve chronic GVHD-free survival following hematopoietic stem cell transplantation in adults. Find out more: https://t.co/bNY4G9H0rm
Help your blood cancer patients discover a free educational event where they can hear from blood cancer experts, connect with local support organizations, and meet others in the community.T
Thank you, Dr. @salmanf, for helping empower the blood cancer community.
Learn more: https://t.co/FdguJkuqJI
#BloodCancer #Pittsburgh
Honored to present leukemia updates at the 2026 Best of ASCO® Portland, August 8–9. Thank you to Co-Chairs Dr. Alexandra Zimmer and Dr. Sudhir Isharwal and the Total Health team. Complimentary registration; CME/MOC available.
@TotalHealthConf@UPMCHillmanCC#ASCO2026#Leukemia
Excited to be part of MPN Awareness: Meet the Experts on September 9 in Pittsburgh!
Looking forward to joining Dr. John Byrd and Dr. James Rossetti to discuss the latest advances in the diagnosis and management of myeloproliferative neoplasms (MPNs), connect with patients, families, and caregivers, and answer your questions.
Hope to see you there!
If you’d like to attend, please RSVP to Jean Diesch at [email protected].
#MPNNews #mpnsm #Leukemia @BloodCancerUtd #UPMC #HillmanCancerCenter @GMPNAN@MPN_Hub
Had a fantastic time last night in Pittsburgh speaking at the IVBM Oncology event: "Pioneering the Next Era of Oncology Care," presented by AJMC!
During my session, "Scaling Innovation: Delivering Targeted Therapies, CAR-T & Bispecifics in Multiple Myeloma," we had an incredibly productive conversation about operational realities.
A few highlights from our discussion:
Treatment Selection: CAR T-cell products vs approved bispecific antibodies for multiple myeloma.
Site of Care: We discussed the shift toward outpatient administration of bispecifics
Expanding Access: We addressed the need for bringing these therapies from academic hubs directly to patients in community-based network sites.
Thank you to @AJMC_Journal
#Oncology #MultipleMyeloma #CARTcell #Bispecifics #MedTwitter #AJMC @UPMCHillmanCC
I’m pleased to participate in HealthTree Connect to Cures in Pittsburgh!
Join me for “Big Decisions in Blood Cancer,” an interactive discussion and Q&A for patients and caregivers.
📅 August 29, 2026
🕘 9:15 AM
📍 The Westin Pittsburgh
@HealthTree@BloodCancerUtd@aamdsif@MDSFoundation@IMFmyeloma@MPN_RF@UPMCHillmanCC
#BloodCancer #Hematology #HealthTree